483
VIRGIN SCENT INCFDA 483 - VIRGIN SCENT INC - March 11, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of VIRGIN SCENT INC, an OTC drug repacker and distributor in Gardena, CA, revealed significant deficiencies in their quality system, distribution controls, and production records. The firm lacked a quality control unit, failed to maintain distribution records for hand sanitizer products, and did not prepare batch production records for repacked drugs. These findings indicate a severe lack of adherence to current Good Manufacturing Practices.
Open in Dashboard
ID · db89389a-e516-4716-9bb3-8a1065e418e7